The American Society for Clinical Investigation (ASCI) honors W. Kimryn Rathmell, MD, PhD, with the 2025 ASCI/Stanley J. Korsmeyer Award. Dr. Rathmell is recognized for her contributions to understanding the biologies driving cancer arising in the kidney and her advocacy for the careers of physician-scientists. Dr. Rathmell recently became CEO of The Ohio State University (OSU) Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. She is former director of the National Cancer Institute (NCI), before which she was Hugh Jackson Morgan Professor in the Department of Medicine at Vanderbilt University Medical Center and served on the faculty of the University of North Carolina at Chapel Hill. Dr. Rathmell was elected to the National Academy of Medicine and the American Academy of Arts and Sciences, is a fellow of the American Association for the Advancement of Science, and is a past president of the ASCI (2019–2020). Dr. Benjamin D. Humphreys, MD, PhD, ASCI Past President (2023–2024), Joseph Friedman Professor of Renal Diseases in Medicine, and Chief of the Division of Nephrology at Washington University in St. Louis, interviewed Dr. Rathmell at the AAP/ASCI/APSA Joint Meeting in Chicago in April 2025.